Caplin Point Laboratories P/B Ratio
Caplin Point Laboratories (CAPLIPOINT) P/B ratio is 6.3 (High), book value per share ₹2420.67 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Read CAPLIPOINT dividend yield for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
CAPLIPOINT P/B Ratio — Valuation Insights & Book Value Analysis
Caplin Point Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 6.3 (High). For live price, earnings yield and the full fundamental profile, see Caplin Point Laboratories stock price NSE.
- Stock appears overvalued with PB of 6.3, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 474.8% above historical average
- Trading at premium to sector average PB of -0.01
Caplin Point Laboratories P/B Ratio Historical Trend
CAPLIPOINT annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Explore CAPLIPOINT fundamental worth to estimate fundamental worth using multiple valuation models.
CAPLIPOINT Historical P/B Ratio — Book Value Per Share & Year-End Price
Caplin Point Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 1.14 | ₹2420.67 | ₹2748.60 | ₹3,631 | Moderate |
| 2025 | 0.96 | ₹1924.0 | ₹1838.10 | ₹2,886 | Low |
| 2024 | 1.6 | ₹1564.67 | ₹2500.65 | ₹2,347 | Moderate |
| 2023 | 1.07 | ₹1271.33 | ₹1356.15 | ₹1,907 | Moderate |
| 2022 | 0.71 | ₹1006.67 | ₹713.30 | ₹1,510 | Low |
CAPLIPOINT vs Healthcare Peers — P/B Ratio Comparison
Caplin Point Laboratories P/B 6.3 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |